566150
Last Update Posted: 2020-03-31
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
35 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Levetiracetam in the Management of Bipolar Depression
A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.
Eligibility
Relevant conditions:
Bipolar Depression
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov